• CircRNA-vgll3 Promotes ADSC Osteogenesis

  2026-09-25

  The study identifies circRNA-vgll3 as a positive regulator of osteogenic differentiation in adipose-derived mesenchymal stem cells, acting through a miR-326-5p–integrin α5 pathway. Cell-based mechanistic experiments and a rat defect model suggest that engineering ADSCs with this circRNA may improve bone formation, although translation beyond the tested model requires further validation.

• EZ Cap Cy5 Firefly Luciferase mRNA: R1010 Guide

  2026-09-25

  EZ Cap Cy5 Firefly Luciferase mRNA combines a Cy5 fluorescence readout of labeled RNA with a firefly luciferase readout of translated protein. This guide explains the product specifications, practical interpretation limits, and how the 5-moUTP modified mRNA can support delivery and translation studies.

• Neuroligin 1 Loss in D2 Neurons Drives Repetitive Behavior

  2026-09-24

  This study links Neuroligin 1 loss in dorsal-striatal D2 medium spiny neurons to excessive self-grooming and digging in mice, combining behavioral, neuronal-activity, and molecular evidence. Its central contribution is to connect cell-type-specific D2-MSN hyperactivity and protein kinase C overactivation with repetitive behavior, while showing that reducing D2-MSN activity can lessen the behaviors measured.

• Cy5-UTP for Reading LNP Trafficking Bottlenecks

  2026-09-24

  Cy5-UTP enables direct fluorescent RNA tracking, but signal location is not the same as successful delivery. Learn how to use Cyanine 5-uridine triphosphate to distinguish trafficking patterns from functional RNA delivery and interpret cholesterol-related bottlenecks.

• Targeted mRNA Nanoparticles After Ischemic Stroke

  2026-09-23

  Gao and colleagues developed mannose-receptor-targeted lipid nanoparticles to deliver IL-10 mRNA to microglia in ischemic brain regions. In mouse stroke models, the treatment promoted anti-inflammatory microglial states, improved blood–brain barrier outcomes, and reduced neurological deficits, supporting further investigation of targeted mRNA therapy beyond the acute treatment window.

• ARCA Cy5 EGFP mRNA: Readouts That Explain Delivery

  2026-09-23

  ARCA Cy5 EGFP mRNA (5-moUTP) enables researchers to separate cellular uptake from productive translation in mammalian cells. This article presents a mechanistic assay framework for interpreting fluorescent mRNA data and translating delivery-material findings into better experimental decisions.

• ARCA Cy5 EGFP mRNA (5-moUTP): Delivery Readouts

  2026-09-22

  ARCA Cy5 EGFP mRNA (5-moUTP) provides orthogonal readouts for cargo uptake and productive translation. This article applies those readouts to spatially controlled delivery research, including the LNP-stabilized emulsion framework reported for targeted antigen presentation.

• Cy5-UTP for RNA Trafficking Assays

  2026-09-22

  Cy5-UTP enables direct fluorescent RNA probe synthesis for FISH and related localization assays. This guide connects Cyanine 5-uridine triphosphate chemistry with the ANXA7–TIA1 axonal trafficking study to show how probe design can strengthen, but not replace, mechanistic interpretation.

• Aztreonam in Reliable Cell Assays

  2026-09-21

  This scenario-driven guide explains how Aztreonam, SKU A5931, can be incorporated into cell viability, proliferation, cytotoxicity, and Gram-negative research workflows. It covers mechanism, cell-model compatibility, stock preparation, resistance interpretation, and practical supplier-selection criteria using product data and recent resistance literature.

• Microfluidic Peptide/RNA Complexes for Pulmonary Delivery

  2026-09-21

  This 2025 study examined whether microfluidic mixing could produce reproducible peptide–RNA complexes that remain suitable for pulmonary nebulisation. Both LAH4-L1 and PEG12KL4 preserved RNA binding and in vitro transfection performance after vibrating-mesh nebulisation, supporting their further evaluation as non-viral pulmonary delivery systems.

• Meropenem trihydrate in Resistance Research

  2026-09-20

  Use Meropenem trihydrate to connect growth inhibition, resistance phenotyping, and metabolomics in reproducible bacterial workflows. This guide translates recent LC-MS/MS findings into practical assay design, optimization, and troubleshooting strategies for antibiotic resistance studies.

• Isoproterenol sulfate dihydrate for SAN Assays

  2026-09-19

  Use Isoproterenol sulfate dihydrate as a controlled beta-adrenergic challenge to distinguish intrinsic pacemaker maturation from acute neuro-cardiac modulation in human SAN assembloids. This workflow combines dose-controlled physiology, cAMP/PKA pathway readouts, and compartment-specific controls for more interpretable cardiovascular research.

• ARCA Cy5 EGFP mRNA (5-moUTP) for Assays

  2026-09-18

  Learn how ARCA Cy5 EGFP mRNA (5-moUTP), SKU R1009, can separate delivery, localization, and translation variables in mammalian-cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay compatibility, handling, interpretation, and practical product-selection criteria.

• CHIR-99021 Workflows for Wnt and Stem Cells

  2026-09-18

  CHIR-99021 (CT99021) provides selective, cell-permeable GSK-3α/β inhibition for controlling pluripotency, lineage commitment, and Wnt-responsive degradation assays. This guide translates its molecular profile into practical stem-cell workflows, with special attention to pulse timing, solvent handling, reporter design, and troubleshooting pathway-specific effects.

• Triacetin Workflows for Cell and Metabolic Research

  2026-09-17

  Triacetin, or glyceryl triacetate, supports distinct glioblastoma, metabolic, ocular-formulation, and lipid-focused workflows. This practical guide separates reported biological activity from formulation utility, with concentration selection, controls, and troubleshooting steps for reproducible assays.

8055 records 1/537 page Next 12345 下5页 Last page